EN DE
Watch China Health Management Corp for free: we tell you when fair value or trend changes.
Data-driven stock valuation

China Health Management Corp (CNHC) fair value: what the stock is really worth

As of Oct 23, 2026: fair value (intrinsic value) of China Health Management Corp stock $0.00, price $0.00, upside +5.9%, quality 59 out of 100. Rating: fairly valued. Calculated from audited financials with 9 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Real Estate US · Based in Taiwan

CH China Health Management Corp logo Thin data Nov 6, 2026

China Health Management Corp

CNHC · US
Neutral

The stock costs about what our calculation considers fair.

Generates free cash flow
Even on cautious assumptions the value is 6% above the price ($0.0043).
Fair value $0.0043 · Fairly valued (+5.9%)
Quality 59/100
Mixed Growth
Loss over the last twelve months · -23.8% net margin (TTM) · fiscal year 2026 3.4%
Negative equity (buybacks among others)
Mixed vs. peers (4/8)
Narrow moat 13/100 · thin data
Thin data
⚠ Thinly traded
Watch China Health Management Corp for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$0.0294 $0.0005 Fair Value $0.0043 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.

How to read this chart

60‑month range $0.0005 – $0.0294 · fair‑value band $0.0043 – $0.0048 · the $0.0041 price screens below the $0.0043 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.

Follow China Health Management in your weekly email

Every Wednesday you see whether China Health Management is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

China Health Management Corp. operates as a healthcare and management company in China. It focuses on the operation and management of hospitals.

Show moreShow less

The company provides healthcare services in the areas of gynaecology and obstetrics, paediatrics, stomatology, dermatology, medical cosmetology, pathology, ophthalmology and otolaryngology, anesthesia, and haemodialysis.

Its services also include surgery, emergency medicine, intensive care, preventive medicine, pharmacy, psychological consultation therapy, medical consultation, combined Chinese and Western medicine, medical examination, medical imaging, medical functions examination, commissioning hospital management, hospital management consultation, etc.

The company was formerly known as Max Internet Communications, Inc. and changed its name to China Health Management Corp. in March 2006. China Health Management Corp. was incorporated in 1996 and is based in Dallas, Texas.

Stock analysis

China Health Management Corp (CNHC) currently trades at $0.0041, while our model-based Fair Value estimate is $0.0043, so the stock looks roughly fairly valued today (gap 5.5%).

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of $0.0300 per share, and 9 of the 9 models we run sit above the $0.0041 price.

Bear case: the DCF Models group reads lowest at $0.0100, and 0 of the 9 models stay below the price. Data coverage for this calculation is low.

Scenario range: $0.0043 (bear) to $0.0048 (bull), the price of $0.0041 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 59/100 (solid quality), in the Real Estate sector.

Mixed Growth: Spin-off in 2026: revenue and profit before it include the divested business. Growth is measured afresh from 2026.

China Health Management Corp reported revenue of $40.0K in FY2026 versus $542K in FY2008, a compound −13.5%/yr. Reported net income was $1.4K in FY2026.

Key figures

Market cap $333K Micro · P/S ratio 0.61 · EPS (TTM) $−0.0010 · Net margin −23.8% · Return on assets (EBIT) 0.1% (4-year average) · Operating margin −1,064% · Revenue growth (YoY) −0.9% · Free cash flow $113K.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 13 out of 100 (low confidence).

What moves the price

The share trades about 37% below its 52-week high and 720% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Real Estate peers we cover trades at −16% fair-value upside, at 6%, CNHC screens cheaper than that median.

Fair Value models

Bear $0.0043 Fair Value $0.0043 Bull $0.0048
Price $0.0041 · Upside +5.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF $0.0200 $0.0300 $0.0400 81
Growth DCF $0.0200 $0.0300 $0.0400 79
Owner Earnings n/a $0.0100 $0.0100 75
All 9 models by family
DCF Models
FCF DCF $0.0200 $0.0300 $0.0400 81
Owner Earnings n/a $0.0100 $0.0100 75
5Y Revenue Exit $0.0100 $0.0100 $0.0100 74
5Y EBITDA Exit $0.0100 $0.0100 $0.0200 73
5Y P/E Exit $0.0100 $0.0100 $0.0100 72
10Y Revenue Exit $0.0100 $0.0100 $0.0200 65
10Y EBITDA Exit $0.0100 $0.0200 $0.0200 70
10Y P/E Exit $0.0100 $0.0100 $0.0100 65
Growth DCF
Growth DCF $0.0200 $0.0300 $0.0400 79

Open the full fair value analysis →

Quality Score breakdown

Overall quality 59/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 13
How much profit the company makes from its sales and capital
Quality Growth 51
Are margins and returns getting better?
Cashflow 100
Do the profits arrive as real cash?
Financial strength 36
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 62
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 76
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 55/100
Spin-off in 2026: revenue and profit before it include the divested business. Growth is measured afresh from 2026.
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−18,123.3% (1998) → 56.1% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−26.1%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −27.8% a year for the price.

Watch CNHC, get fair value alerts →

Compare China Health Management Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate Services · 472 stocks

Beats the industry median on 4/8 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 59 · Above median
Fair Value upside +5.9% · Below median
Profitability
Return on equity (12 months) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets 0.2% · Below median
Net margin (12 months) −23.8% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −0.9% · Below median
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Real Estate Services median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months) 0.61× · Cheapest 25%
Price / free cash flow (fiscal year) 3.0× · Cheapest 25%
EV/EBITDA 12.8× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)41 · sector 55
FUTURE (revenue growth)0 · sector 19
PAST (return on equity)0 · sector 19
HEALTH (low debt)0 · sector 83
DIVIDEND (yield)0 · sector 66

PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Real Estate Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Vonovia SE VNA €16.90 €36.43 +116% vs CNHC
Jones Lang LaSalle Incorporated JLL $370.80 $529.78 +43% vs CNHC
China Resources Mixc Lifestyle Services Limited 1209 HK$41.64 HK$55.21 +33% vs CNHC
Cellnex Telecom, S.A CLNX €26.68 €23.62 −11% vs CNHC
Wharf Real Estate Investment Company 1997 HK$32.54 HK$27.21 −16% vs CNHC
CBRE Group CBRE $135.51 $89.81 −34% vs CNHC
KE Holdings BEKE $18.85 $7.33 −61% vs CNHC
CapitaLand Investment Limited 9CI 2.36 SGD 0.7800 SGD −67% vs CNHC
Swire Properties Limited 1972 HK$26.36 HK$5.88 −78% vs CNHC
CoStar Group CSGP $30.55 $6.09 −80% vs CNHC

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Evidence & backtest34 years, failed companies included Financial calculatorsDCF, Graham, PEG and more
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

China Health Management Corp: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "China Health Management Corp Fair Value". https://www.fairvalue-calculator.com/stock/CNHC

Frequently asked questions

Is China Health Management Corp (CNHC) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of $0.0043 versus the last price from Oct 23, 2026 of $0.0041, about +6% upside (fairly valued).
What is the fair value of CNHC?
Our model-based fair value for China Health Management Corp is $0.0043 (as of Nov 6, 2026), built from audited fundamentals. Last price (from Oct 23, 2026): $0.0041.
What is the quality score of CNHC?
China Health Management Corp has a Quality Score of 59/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for China Health Management Corp (CNHC)?
Our model-based price target is the fair value of $0.0043 (as of Nov 6, 2026) from 9 valuation models. Cautious scenario $0.0043, optimistic scenario $0.0048. It is a calculation from audited fundamentals, not an analyst target.
What is the China Health Management Corp stock forecast for 2026?
Our models put fair value at $0.0043, about +6% upside versus the last price from Oct 23, 2026 of $0.0041 (fairly valued). Cautious scenario $0.0043, optimistic scenario $0.0048. The calculation is refreshed regularly with new filings.
What growth is priced into China Health Management Corp (CNHC)?
For today's price to be fair in a discounted-cash-flow model, China Health Management Corp would have to grow free cash flow by -26.1 % per year for five years (discount rate 9.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 18 years revenue grew -13.5 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of CNHC use?
Our models discount China Health Management Corp at 9.7 %: a base by market capitalisation (nano), country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For China Health Management Corp that is -26.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.7 %) and the same formula as our fair value.
How much growth has China Health Management Corp (CNHC) delivered so far?
Over the past 18 years revenue at China Health Management Corp grew -13.5 % a year. The price currently implies free-cash-flow growth of -26.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of China Health Management Corp (CNHC) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into China Health Management Corp (-26.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of China Health Management Corp (CNHC)?
The free-cash-flow yield on the price is 33.85 %: that much free cash flow China Health Management Corp produces per unit of market value. When it exceeds the discount rate of our models (9.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of China Health Management Corp (CNHC)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For China Health Management Corp it is $0.0043 per share (as of Nov 6, 2026), against a price of $0.0041. It is the blended result of 9 valuation models in 2 families (DCF Models, Growth DCF).
Is China Health Management Corp stock overvalued or undervalued in 2026?
As of Nov 6, 2026, CNHC trades below its calculated fair value: price $0.0041, fair value $0.0043, a gap of about +6% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CNHC?
No. The price is what the market pays today ($0.0041); the fair value is what the company's own numbers justify ($0.0043). For China Health Management Corp the two are $0.0002 per share apart. That gap is exactly why we show both numbers side by side.
How much is China Health Management Corp worth?
The market values China Health Management Corp at about $333K (market capitalisation, as of Nov 6, 2026). Per share that is $0.0041; our models calculate a fair value of $0.0043 per share.
What do the bullish and bearish scenarios say about CNHC?
Our models span a range for China Health Management Corp: cautious scenario $0.0043, base $0.0043, optimistic $0.0048 per share (as of Nov 6, 2026, price $0.0041). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of China Health Management Corp (CNHC)?
Balance-sheet figures for China Health Management Corp (as of Nov 6, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 59/100, which measures business quality independently of the share price.
How far is CNHC from its 52-week high?
China Health Management Corp trades at $0.0041, about 37% below its 52-week high of $0.0065 and 720% above the low of $0.0005 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0043 is for.
Which stocks are comparable to China Health Management Corp?
From the same area (Real Estate) we also value CBRE Group, Cellnex Telecom, S.A, KE Holdings, Swire Properties Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is China Health Management Corp stock attractive at the current price?
The data as of Nov 6, 2026: price $0.0041, calculated fair value $0.0043 (+6%), Quality Score 59/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CNHC calculated?
We run China Health Management Corp through 9 models from 2 families: DCF Models, Growth DCF. Every model gets the same audited fundamentals; the fair value of $0.0043 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0% above its aggregate fair value. China Health Management Corp currently trades 6% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of China Health Management Corp (CNHC)?
The latest price we hold is from Oct 23, 2026 and stands at $0.0041. Our model-based fair value is $0.0043, about +6% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with China Health Management Corp right now?
The price is below even our cautious bear case ($0.0043). The market is more pessimistic than our downside scenario. The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band ($0.0043 to $0.0048), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of China Health Management Corp

How large is the market capitalisation of China Health Management Corp (CNHC)?
The market capitalisation of China Health Management Corp is $333K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of China Health Management Corp (CNHC)?
The price-to-sales ratio of China Health Management Corp is 0.61 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of China Health Management Corp (CNHC)?
Earnings per share at China Health Management Corp are $−0.0010. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of China Health Management Corp (CNHC)?
The net margin of China Health Management Corp is −23.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of China Health Management Corp (CNHC)?
On an EBIT basis the return on assets of China Health Management Corp is 0.1% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of China Health Management Corp (CNHC)?
The operating margin of China Health Management Corp is −1,064% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at China Health Management Corp (CNHC)?
Revenue at China Health Management Corp is growing −0.9% versus a year earlier (3y avg +13.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does China Health Management Corp (CNHC) carry?
The net debt of China Health Management Corp is $476K (fiscal year 2026, ≈ 4.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch China Health Management Corp in the live analysis

One click puts China Health Management Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.